Suppr超能文献

[3H]CGP-12177的低β1-肾上腺素能受体选择性在解决竞争性配体亚型选择性方面的作用。

The role of a low beta 1-adrenoceptor selectivity of [3H]CGP-12177 for resolving subtype-selectivity of competitive ligands.

作者信息

Nanoff C, Freissmuth M, Schütz W

机构信息

Institute of Pharmacology, University of Vienna, Austria.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 1987 Nov;336(5):519-25. doi: 10.1007/BF00169308.

Abstract

On the basis of saturation binding studies on rat cardiac microsomes, which contained a mixed population of beta-adrenoceptor subtypes, [3H]CGP-12177 is presumed to be a non-selective beta-adrenergic radioligand. However, saturation binding studies carried out in the presence of subtype-saturating concentrations of the beta 2-selective antagonist ICI 118,551 and the beta 1-selective antagonist ICI 89,406, respectively, revealed a KD for beta 1-adrenoceptors of 0.33 +/- 0.02 nmol/l and a KD for beta 2-adrenoceptors of 0.90 +/- 0.14 nmol/l. Competition experiments with the highly selective antagonists revealed greatly different competition binding curves in the presence of either [3H]CGP-12177 or (-)[125I]iodocyanopindolol (ICYP), a beta-adrenergic radioligand considered to be as non-selective as [3H]CGP-12177. The following results are further suggestive for a selectivity of [3H]CGP-12177 for beta 1-adrenoceptors: (1) Using non-linear regression analysis, a significantly lower selectivity (expressed as the ratio of the IC50 for beta 2-adrenoceptors to the IC50 for beta 1-adrenoceptors) as well as a larger proportion of beta 1-adrenoceptors were calculated by competition of the beta 1-selective antagonist ICI 89,406 with [3H]CGP-12177 binding than by competition of ICI 89,406 with ICYP binding; (2) reducing the [3H]CGP-12177 concentration from 2 to 0.4 nmol/l, competition experiments with ICI 89,406 led to an increase in the estimated selectivity of the competitor and in the estimated proportion of beta 1-adrenoceptors; (3) reverse findings were obtained with ICI 118,551, a beta 2-selective antagonist.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

基于对大鼠心脏微粒体的饱和结合研究(其中包含多种β-肾上腺素能受体亚型),[3H]CGP - 12177被推测为一种非选择性β-肾上腺素能放射性配体。然而,分别在β2选择性拮抗剂ICI 118,551和β1选择性拮抗剂ICI 89,406的亚型饱和浓度存在下进行的饱和结合研究显示,β1肾上腺素能受体的KD为0.33±0.02 nmol/L,β2肾上腺素能受体的KD为0.90±0.14 nmol/L。与高选择性拮抗剂的竞争实验表明,在存在[3H]CGP - 12177或(-)[125I]碘氰吲哚洛尔(ICYP,一种被认为与[3H]CGP - 12177一样非选择性的β-肾上腺素能放射性配体)的情况下,竞争结合曲线有很大差异。以下结果进一步表明[3H]CGP - 12177对β1肾上腺素能受体具有选择性:(1)使用非线性回归分析,通过β1选择性拮抗剂ICI 89,406与[3H]CGP - 12177结合的竞争计算得出的选择性(表示为β2肾上腺素能受体的IC50与β1肾上腺素能受体的IC50之比)显著低于通过ICI 89,406与ICYP结合的竞争计算得出的结果,且β1肾上腺素能受体的比例更大;(2)将[3H]CGP - 12177浓度从2 nmol/L降至0.4 nmol/L,与ICI 89,406的竞争实验导致竞争者的估计选择性和β1肾上腺素能受体的估计比例增加;(3)β2选择性拮抗剂ICI 118,551得到了相反的结果。(摘要截短于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验